Calamos Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-169,936
| Closed | -$31.2M | – | 1109 |
|
|
2021
Q2 | $31.2M | Buy |
169,936
+28,983
| +21% | +$4.98M | 0.16% | 185 |
|
|
2021
Q1 | $21.6M | Buy |
140,953
+23,325
| +20% | +$3.61M | 0.13% | 195 |
|
|
2020
Q4 | $18.4M | Buy |
117,628
+8,468
| +8% | +$1.09M | 0.11% | 226 |
|
|
2020
Q3 | $12.5M | Sell |
109,160
-9,580
| -8% | -$1.03M | 0.09% | 256 |
|
|
2020
Q2 | $13.3M | Sell |
118,740
-289,115
| -71% | -$30.7M | 0.1% | 239 |
|
|
2020
Q1 | $36.6M | Sell |
407,855
-276,100
| -40% | -$27.1M | 0.29% | 98 |
|
|
2019
Q4 | $74M | Buy |
683,955
+102,242
| +18% | +$10.9M | 0.41% | 68 |
|
|
2019
Q3 | $57M | Sell |
581,713
-67,510
| -10% | -$7.61M | 0.33% | 87 |
|
|
2019
Q2 | $85M | Sell |
649,223
-38,409
| -6% | -$4.95M | 0.51% | 45 |
|
|
2019
Q1 | $93M | Sell |
687,632
-46,730
| -6% | -$5.81M | 0.62% | 34 |
|
|
2018
Q4 | $71.5M | Buy |
734,362
+18,083
| +3% | +$2.14M | 0.51% | 48 |
|
|
2018
Q3 | $99.6M | Buy |
716,279
+93,533
| +15% | +$11.7M | 0.66% | 34 |
|
|
2018
Q2 | $77.3M | Buy |
622,746
+27,168
| +5% | +$3.18M | 0.54% | 39 |
|
|
2018
Q1 | $66.4M | Buy |
595,578
+113,946
| +24% | +$13.6M | 0.48% | 50 |
|
|
2017
Q4 | $57.6M | Buy |
481,632
+190,921
| +66% | +$23.3M | 0.44% | 59 |
|
|
2017
Q3 | $40.8M | Sell |
290,711
-43,777
| -13% | -$5.95M | 0.32% | 89 |
|
|
2017
Q2 | $40.7M | Buy |
334,488
+268,287
| +405% | +$31.2M | 0.33% | 86 |
|
|
2017
Q1 | $8.03M | Buy |
66,201
+45,119
| +214% | +$5.82M | 0.06% | 303 |
|
|
2016
Q4 | $2.58M | Sell |
21,082
-256,494
| -92% | -$31.4M | 0.02% | 449 |
|
|
2016
Q3 | $34M | Sell |
277,576
-217,463
| -44% | -$28M | 0.24% | 135 |
|
|
2016
Q2 | $57.8M | Sell |
495,039
-34,347
| -6% | -$4.87M | 0.41% | 69 |
|
|
2016
Q1 | $73.7M | Buy |
529,386
+6,202
| +1% | +$911K | 0.49% | 52 |
|
|
2015
Q4 | $99.8M | Buy |
523,184
+193,450
| +59% | +$33.8M | 0.64% | 33 |
|
|
2015
Q3 | $51.6M | Buy |
329,734
+226,350
| +219% | +$41.3M | 0.36% | 85 |
|
|
2015
Q2 | $18.7M | Buy |
103,384
+82,261
| +389% | +$14.2M | 0.12% | 203 |
|
|
2015
Q1 | $3.66M | Sell |
21,123
-19,086
| -47% | -$3.45M | 0.02% | 416 |
|
|
2014
Q4 | $7.44M | Buy |
40,209
+209
| +0.5% | +$38.7K | 0.05% | 305 |
|
|
2014
Q3 | $6.63M | Sell |
40,000
-1,620
| -4% | -$266K | 0.04% | 303 |
|
|
2014
Q2 | $6.5M | Buy |
41,620
+21,620
| +108% | +$3.41M | 0.04% | 309 |
|
|
2014
Q1 | $3.04M | Sell |
20,000
-9,000
| -31% | -$1.43M | 0.02% | 385 |
|
|
2013
Q4 | $3.86M | Buy |
29,000
+12,000
| +71% | +$1.44M | 0.02% | 350 |
|
|
2013
Q3 | $1.98M | Hold |
17,000
| – | – | 0.01% | 416 |
|
|
2013
Q2 | $1.57M | Buy |
+17,000
| New | +$1.64M | 0.01% | 422 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM